search
Back to results

Comparison of the Capsular Stability With Two Different IOL Models in Patients With Pseudoexfoliation Syndrome: an Exploratory Study

Primary Purpose

Cataract

Status
Unknown status
Phase
Not Applicable
Locations
Austria
Study Type
Interventional
Intervention
ISERT 250 (HOYA, Japan): a standard IOL
AMO ZCB00 IOL (Abbott Medical Optics, United States): a standard IOL
Sponsored by
Vienna Institute for Research in Ocular Surgery
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Cataract

Eligibility Criteria

21 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Age-related cataract
  • Age 21 and older
  • Pseudoexfoliation syndrome
  • written informed consent prior to surgery

Exclusion Criteria:

  • Relevant ophthalmic diseases that could affect corneal transparency or the ability for fixation of LEDs
  • In case of pregnancy (pregnancy test will be taken preoperatively in women of reproductive age)

Sites / Locations

  • VIROS - Vienna Institute for Research in Ocular Surgers - Departement of Opthalmology - Hanusch HospitalRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Other

Active Comparator

Arm Label

AMO ZCB00

ISERT 250

Arm Description

AMO ZCB00 IOL (Abbott Medical Optics, United States): a standard IOL

ISERT 250 (HOYA, Japan): a standard IOL

Outcomes

Primary Outcome Measures

Difference between the two IOLS in postoperative IOL tilt (degrees) and decentration (mm) measured with the Purkinjemeter

Secondary Outcome Measures

Horizontal and vertical IOL tilt (in °) evaluated from AS-OCT and Scheimpflug images
Change in rhexis diameter (mm in retroillumination foto)
Change in anterior chamber depth (in mm) measured with the AC Master
Subjective evaluation of IOL - anterior capsule interconnection ( capsule overlapping the IOL optic edge in slitlamp examination)
Change in aqueous flare measured with laser flare meter

Full Information

First Posted
June 2, 2014
Last Updated
June 3, 2014
Sponsor
Vienna Institute for Research in Ocular Surgery
search

1. Study Identification

Unique Protocol Identification Number
NCT02155478
Brief Title
Comparison of the Capsular Stability With Two Different IOL Models in Patients With Pseudoexfoliation Syndrome: an Exploratory Study
Official Title
Comparison of the Capsular Stability With Two Different IOL Models in Patients With Pseudoexfoliation Syndrome: an Exploratory Study
Study Type
Interventional

2. Study Status

Record Verification Date
June 2014
Overall Recruitment Status
Unknown status
Study Start Date
February 2013 (undefined)
Primary Completion Date
February 2015 (Anticipated)
Study Completion Date
February 2015 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Vienna Institute for Research in Ocular Surgery

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The pseudoexfoliation (PXF syndrome) is caused by production and deposition of extracellular material in the anterior chamber of the eye as well as in other tissues of the body. Approx. 70 million worldwide have a PXF syndrome. After cataract surgery a decentration and subluxation of the intraocular lens (IOL) happens more frequently than in the general population due to a higher incidence of zonular weakness and an increased capsular fibrotic reaction. Decentration, tilt and / or rotation of the lens can reduce the quality of vision. It is believed that the design of the implanted IOL, more precisely the front surface of the IOL has an influence on the extent of capsular fibrosis and contraction. Especially in presence of capsular instability, as it is in patients with Pseudoexfoliation syndrome the design of the IOL has an effect on the post-operative stability. In this study, two different IOL models are compared in terms of their stability. The "Tecnis 1-piece ZCB00" (AMO, USA), with a concave lowering comprising the lens edge and the "Acrysof SA60AT" (Alcon, USA), with a biconvex design are compared. Forty eyes of 20 patients are planned to be included in this study. One eye receives the "Tecnis ZCB00 1-piece "(AMO, USA), while the other eye receives the"Acrysof SA60AT "(Alcon, USA). In which eye which IOL is implanted, is assigned by randomization. To measure the decentration, tilt and rotation of the IOL an examination will be performed before the operation and there will be follow-ups one hour after the operation of the first eye, one hour after the operation of the second eye, three months and twelve months after the operation on the second eye. All measurements will be done without touching the eye.
Detailed Description
Pseudoexfoliation (PXF) is an age-related disease characterized by production of extracellular material in the anterior segment of the eye and other tissues of the body. While only 0.6% of people between 52 and 65 years are affected, 5% of people between 75 years and 85 years have Pseudoexfoliation syndrome. An estimated 70 million people may have PXF worldwide. PXF can be associated with glaucoma, cataract, reduced pupil dilatation, zonule weakness, and postoperative complications. After cataract surgery decentration and subluxation of the intra-ocular lens (IOL) is more likely in patients with Pseudoexfoliation syndrome due to the higher incidence of zonular weakness as well as the increased capsule fibrotic reaction. It has to be taken into account that an anterior chamber depth (ACD) shift, decentration, tilt or rotation of an IOL could result in a severe reduction in visual quality. For an aspherical IOL, for instance, it is essential not to be decentered and tilted more than 0.4 mm (0.8 mm 7) and 7° (10° 7), respectively. Otherwise it will be outperformed by a spherical IOL. We assume that the design of the IOL, more precisely the design of the anterior surface of the IOL, can influence the degree of capsule fibrosis and contraction, especially in patients who tend to have capsular instability like patients with PXF syndrome. The Tecnis 1-piece ZCB00 (AMO, California, USA), a single-piece hydrophobic acrylic open-loop IOL has its convex anterior surface not up to the edge of the IOL optic, but instead has a concave depression before reaching the edge. Due to this particular shape of the anterior surface, the anterior lens capsule typically only has contact at the IOL optic edge with the remaining central part up to the rhexis edge 'floating' over the optic without contact. Due to this situation, we expect less fibrotic reaction of the capsule because of a lack of contact between the lens epithelial cells of the anterior capsule not transdifferentiating into myofibroblasts and not laying down collagen that result in the typical contraction and whitening of the anterior capsule. On the contrary, another IOL, the ISERT 250 (HOYA, Japan), also a hydrophobic acrylic open-loop IOL, has an anterior surface which is convex all the way to the optic edge resulting in complete contact of the rhexis edge and overlying the anterior capsule on the IOL optic. This may aggravate the anterior lens capsule reaction to the IOL material which may result in more capsular contraction due to pronounced fibrosis of the capsule and in turn results in decentration and or tilt of the IOL. Aim of this study is to assess the differences of IOL tilt and decentration in patients with pseudoexfoliation syndrome (PXF) with two different IOLs, the Tecnis 1-piece ZCB00, (AMO, USA) and the ISERT 250 (HOYA, Japan), measured with an AS-OCT, Scheimpflug imaging and Purkinjemeter.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cataract

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
30 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
AMO ZCB00
Arm Type
Other
Arm Description
AMO ZCB00 IOL (Abbott Medical Optics, United States): a standard IOL
Arm Title
ISERT 250
Arm Type
Active Comparator
Arm Description
ISERT 250 (HOYA, Japan): a standard IOL
Intervention Type
Device
Intervention Name(s)
ISERT 250 (HOYA, Japan): a standard IOL
Intervention Type
Device
Intervention Name(s)
AMO ZCB00 IOL (Abbott Medical Optics, United States): a standard IOL
Primary Outcome Measure Information:
Title
Difference between the two IOLS in postoperative IOL tilt (degrees) and decentration (mm) measured with the Purkinjemeter
Time Frame
12 months
Secondary Outcome Measure Information:
Title
Horizontal and vertical IOL tilt (in °) evaluated from AS-OCT and Scheimpflug images
Time Frame
12 months
Title
Change in rhexis diameter (mm in retroillumination foto)
Time Frame
12 months
Title
Change in anterior chamber depth (in mm) measured with the AC Master
Time Frame
12 months
Title
Subjective evaluation of IOL - anterior capsule interconnection ( capsule overlapping the IOL optic edge in slitlamp examination)
Time Frame
12 months
Title
Change in aqueous flare measured with laser flare meter
Time Frame
12 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
21 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Age-related cataract Age 21 and older Pseudoexfoliation syndrome written informed consent prior to surgery Exclusion Criteria: Relevant ophthalmic diseases that could affect corneal transparency or the ability for fixation of LEDs In case of pregnancy (pregnancy test will be taken preoperatively in women of reproductive age)
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Oliver Findl
Organizational Affiliation
ViROS - Vienna Institute for Research in Ocular Surgers - Departement of Opthalmology - Hanusch Hospital Vienna, Vienna, Austria 1140
Official's Role
Principal Investigator
Facility Information:
Facility Name
VIROS - Vienna Institute for Research in Ocular Surgers - Departement of Opthalmology - Hanusch Hospital
City
Vienna
ZIP/Postal Code
1140
Country
Austria
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Oliver Findl, MD, MBA
Phone
+43 1 91021
Ext
84611
Email
oliver@findl.at
First Name & Middle Initial & Last Name & Degree
Nino Hirnschall, MD
First Name & Middle Initial & Last Name & Degree
Sophie Maedel, MD
First Name & Middle Initial & Last Name & Degree
Maria Weber, MD
First Name & Middle Initial & Last Name & Degree
Jörg Wiesinger, MD
First Name & Middle Initial & Last Name & Degree
Petra Draschl, MD

12. IPD Sharing Statement

Learn more about this trial

Comparison of the Capsular Stability With Two Different IOL Models in Patients With Pseudoexfoliation Syndrome: an Exploratory Study

We'll reach out to this number within 24 hrs